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The sonic hedgehog (Shh) signaling pathway plays a fundamental role in the central
nervous system (CNS) development, but its effects on neural cell survival and brain
repair after subarachnoid hemorrhage (SAH) has not been well-investigated. The present
study was undertaken to evaluate the influence of an agonist of the Shh co-receptor
Smoothened (Smo), purmorphamine (PUR), on early brain injury (EBI) as well as the
underlying mechanisms after SAH. PUR was administered via an intraperitoneal injection
with a dose of 0.5, 1, and 5 mg/kg at 2, 6, 24, and 46 h after SAH in rat model.
The results showed that PUR treatment significantly ameliorated brain edema, improved
neurobehavioral function, and attenuated neuronal cell death in the prefrontal cortex
(PFC), associated with a decrease in Bax/Bcl-2 ratio and suppression of caspase-3
activation at 48 h after SAH. PUR also promoted phospho-ERK levels. Additionally, PUR
treatment markedly decreasedMDA concentration accompanied with the elevation in the
expression of nuclear factor erythroid 2-related factor 2 and heme oxygenase-1 in PFC.
Notably, PUR treatment significantly reversed the changes of Shh pathway mediators
containing Patched, Gli1, and Shh by SAH insult, and the neuroprotection of PUR on SAH
was blocked by Smo antagonist cyclopamine. These results indicated that PUR exerts
neuroprotection against SAH-evoked injury in rats, mediated in part by anti-apoptotic and
anti-oxidant mechanism, up-regulating phospho-ERK levels, mediating Shh signaling
molecules in the PFC.
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INTRODUCTION
Increasing body of clinical and experimental data has demonstrated that early brain injury (EBI)
largely contributes to unfavorable outcomes after subarachnoid hemorrhage (SAH; Bederson et al.,
2009). Many studies have shown that elevation of intracranial pressure, oxidative stress, cerebral
perfusion disruption, blood-brain barrier (BBB) damage, cerebral edema, and cell apoptosis
contributed to the development of EBI, however, the exact mechanism of EBI remains elusive
(Sehba et al., 2012).
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The sonic hedgehog (Shh) signaling pathway plays a
fundamental role in the central nervous system (CNS)
development. Shh is a morphogenic protein that binds to
its receptor, Patched (Ptch), on the surface of target cells, and
cause Ptch activation. Ptch activation releases Smoothened (Smo)
to initiate downstream signaling that controls the transcription
factor Gli-1. Then Gli-1 translocates to the nucleus and thereby
regulates the expression of a series of target genes that control
cell growth, survival, and differentiation (Chari and McDonnell,
2007). Recent studies showed the beneficial role of Shh signaling
in various models in the process of neurodegenerative diseases
and brain injury, including acute brain injury (Amankulor
et al., 2009), Parkinson’s disease (Tsuboi and Shults, 2002),
stroke (Huang et al., 2013; Chechneva et al., 2014), multiple
sclerosis and demyelination (Franco et al., 2008), spinal cord
injury (Bambakidis et al., 2010), HIV-associated neurological
disorders (Singh et al., 2016). Moreover, using direct Shh protein
injection, such as administration of recombinant Shh protein
or intravenous hedgehog agonist, Ag11.1, was reported to
improve spinal cord injury in adult rats (Bambakidis et al.,
2003, 2010). The administration of Shh agonist, SAG, can
alleviate HIV-associated neuropathology (Singh et al., 2016).
Purmorphamine (PUR) is a purine-derivative small molecule
agonist of SMO receptors (Sinha and Chen, 2006). In 2002,
Schultz et al. were the first to demonstrate that PUR could
induce osteoblast differentiation of multipotent mesenchymal
progenitor cells (Wu et al., 2002). In addition, PUR increases
resistance of hippocampal neurons against oxidative challenge
and reduces neuronal death (Peterson and Turnbull, 2012). The
protective role of PUR was reported to promote BBB formation
and act as an endogenous anti-inflammatory system (Alvarez
et al., 2011). However, the neuroprotective effects of PUR on
EBI have not been investigated. In the present study, we aimed
to investigate the role of PUR in EBI post-SAH insult and the
underlying mechanism by employing an experimental SAH rat
model.
MATERIALS AND METHODS
Establishing SAH Model
All the procedures were proved by the Ethic Committee of
Medical Department, Shandong University and Qilu Hospital
which conformed to the International Guiding Principles for
Animal Research, as stipulated by theWorldHealthOrganization
(Howard-Jones, 1985).
Adult male Wistar rats weighting 280–350 g were obtained
from Laboratory Animal Center, Shandong University and then
were housed under temperature- and light-controlled laboratory
conditions with free access to food and water for 7 days.
Experimental animals were subjected to SAH by double blood
Abbreviations: CNS, central nervous system; Cyc, cyclopamine; DAPI, 4′,6-
diamidino-2-phenylindole dihydrochloride; ERK, extracellular signal-regulated
kinase; HO-1, heme oxygenase-1; MAPK, mitogen-activated protein kinase; MDA,
malondialdehyde; Nrf2, NF-E2-related factor 2; PBS, phosphate buffered saline;
PFC, prefrontal cortex; Ptch, Patched; PUR, purmorphamine; ROS, reactive
oxygen species; RT-PCR, reverse transcription-polymerase chain reaction; Shh,
sonic hedgehog; Smo, Smoothened.
injection method according to previous study (Li et al., 2016).
Firstly, deep anesthesia was induced under 3.5% isoflurane and
maintained the anesthesia state at a concentration of 2.5%. Then
200 µl autologous blood was withdrawn from the femoral artery
and given into the cisterna magna at a speed of 50 µl per min.
Drug Treatment and Groups Design
Total 162 rats were used in the study. All the rats were
randomly assigned to six groups: sham+vehicle (saline) group,
the SAH+vehicle (saline) group, the SAH+PUR1 (0.5 mg/kg)
group, the SAH+PUR2 (1mg/kg) group, the SAH+PUR3
(5mg/kg) group, and the SAH+PUR (1 mg/kg)+cyclopamine
(Cyc, 1mg/kg). Drug or saline was intraperitoneally given at 2,
6, 24, and 46 h post-SAH. At 48 h after SAH, the animals were
sacrificed for tissue analysis.
Neurological Assessment
Neurological examinations of scoring system (Table 1) were
blindly performed at 48 h after SAH according to previous
research (Cui et al., 2015), monitoring three aspects: appetite,
activity, and neurological deficits. Neurological deficits of the
experimental animals were scored as follows: (i) “no neurologic
deficit” scored as 0; (ii) “potential orminimumneurologic deficit”
scored as 1; (iii) “mild neurologic deficits” scored as 2 or 3; (iv)
“severe neurologic deficit” scored as 4–6.
Brain Water Content
Brain edema was evaluated using the wet/dry method which was
calculated as [(wet weight − dry weight)/wet weight] × 100%.
Brain samples were rapidly removed and weighed immediately
as wet weight at 48 h after SAH. They were subsequently dried
for 48 h at 100◦C and weighed as the dry weight.
Morphological Analysis
The brains were removed quickly on ice and fixed in
formalin. After fixation and dehydration in gradient ethanol,
the tissues were embedded in paraffin and sliced into 4 µm
thickness sections using a section cutter (Leica, Germany).
Three sections/rat were stained with hematoxylin and eosin
(H&E).Morphological observation of prefrontal cortex (PFC, the
cerebral cortex which covers the front part of the frontal lobe)
TABLE 1 | Behavior and activity scores.
Category Behavior Score
Appetite Finished meal 0
Left meal unfinished 1
Scarcely ate 2
Activity Walk and reach at least three corners of the cage 0
Walk with some stimulations 1
Almost always lying down 2
Deficits No deficits 0
Unstable walk 1
Impossible to walk 2
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was obtained from three sections per rat by a light microscope
(Olympus Corporation, Japan). Each group provided four rats for
HE staining.
Injured neurons were identified by their acidophilic
(eosinophilic) cytoplasm and pyknotic nuclei with HE staining
(Medel-Matus et al., 2014). Three microscope areas (40×) in PFC
were obtained and counted damaged cells by a blind manner.
Average of the number of injured cells was obtained from three
sections per rat. For each selected field, only cells with their
nuclei present in the focal plane were counted.
Other sections were used to demonstrate the apoptotic cells
in PFC by terminal deoxynucleotidyl transferase dUTP nick
end labeling (TUNEL) which was operated according to the
manufacturer’s protocol (Dead End Flurometric Kit, Promega,
WI, USA). Three rats for each group were prepared to paraffin
sections for the staining. The slides were counter-stained with
4′,6-diamidino-2-phenylindole (DAPI). Three microscope areas
(20×) of TUNEL-positive cells in PFC were observed and imaged
by a researcher who was blind to the condition. TUNEL/DAPI
positive cells were counted as the mean of the numbers from the
six pictures/rat.
Immunofluorescence Staining Of Cleaved
Caspase-3
Procedures on immunofluorescence staining to detect caspase-
3 activation were as follows: sections were dewaxed with a
standard procedure and washed with PBS. Then the sections
were incubated at 4◦C for 12 h overnight with the primary
antibody (cleaved caspase-3, 1:100, Cell Signaling Tech. MA,
USA; andNeuN, 1:100, Abcam, Cambridge, MA, USA), followed
by the appropriate fluorescent-conjugated secondary antibody
(1:500, Sigma-Aldrich). Three microscope fields (20×) of active
caspase-3/NeuN double positive cells in PFCwere obtained using
a Nikon TE2000Umicroscope by a blindmanner. Active caspase-
3/NeuN double positive cells were recorded as the mean of the
numbers from six pictures/rat. Each group provided four rats for
the staining.
Malondialdehyde (MDA) Content
The tissues from PFC (six mice for each groups) were
homogenized with tissue protein extraction kits (Pierce
Biotechnology, Inc., IL, Rockford, USA) including protease
inhibitors and then centrifuged at 12,000 g for 10 min. The
supernatant was prepared for subsequent analyses of MDA
content, which was assessed with a multiwell spectrophotometer
(Bio-Rad, USA). Measurement of MDA content mainly depends
on the production of lipid peroxidation and was detected using
an assay kit (Jiancheng Inc., Nanjing, China) by thiobarbituric
acid analysis (Draper and Hadley, 1990). The evaluations were
determined by standard protocols and normalized to the protein
content.
Reverse Transcription-Polymerase Chain
Reaction (RT-PCR)
Total RNA was extracted from the PFC tissue through the Trizol
reagent (Gibco, Invitrogen) method. The concentration of total
RNA was then detected by a spectrophotometer (Bio-Rad. Labs)
at 260 nm. Total 2 µg of RNA were reversely transcribed into
cDNA using a RT-PCR kit (Fermentas, Vilnius, Lithuania) and
then was amplified by PCR with specific primers (Table 2). The
products were separated on a 1.2% agarose/TAE gel and stained
with ethidium bromide to visualize. β-actin was recorded as the
internal control. Data on the intensity of bands was collected and
analyzed by Image-Pro Plus 6.0 software.
Western Blot Analysis
Protein concentration in the PFC was determined as reported
previously. Equal quantities of protein were loaded onto a 10–
15% gradient polyacrylamide gel, electrophoretically transferred
to a polyvinylidene difluoride membrane and probed with the
following primary antibodies: Bcl-2 antibody (1:1000, Santa Cruz
Biotechnology, CA, USA), Bax antibody (1:1000, Santa Cruz
Biotechnology), Shh (1:1000, Proteintech.), Gli-1 (1:1000, Santa
Cruz Biotechnology), Ptch (1:1000, Abcam, Cambridge, MA,
USA), caspase-3 (1:500, Cell Signaling Tech. MA, USA), cleaved
caspase-3 (1:1000, Cell Signaling), Phospho-extracellular signal-
regulated kinase (ERK)1/2 (1:2000, Cell Signaling), ERK1/2
(1:2000; Cell Signaling), Nrf2 (1:1000, Proteintech.), HO-1
(1:2000, Proteintech.). β-actin (1:2000; Sigma-Aldrich) was used
as an internal loading control.
Statistical Analysis
Values were expressed as the mean ± SD. Significant difference
was performed with a one-way ANOVA using the post-hoc
Tukey-test for multiple comparisons of means. p < 0.05 was
considered to be a significant difference.
RESULTS
Influence of PUR on Mortality, Neurological
Deficits, and Edema after SAH
Total 162 rats were used for surgeries. And 18 rats died within
1 h after surgery (18/162 operated animals) during which time
the animals had not received either the drug or the vehicle yet.
Within 48 h after surgeries, the mortality in each group was:
sham 0% (0 of 20), SAH+vehicle 17.86% (5 of 28), SAH+PUR1
12.5% (3 of 24), SAH+PUR2 8.33% (2 of 24), SAH+PUR3 4.16%
(1 of 24), SAH+PUR3+Cyc 16.67% (4 of 24). A Pearson chi-
squared analysis revealed that treatment with PUR or Cyc has
no significantly different in mortality as compared to vehicle
treatment in SAH rats (p > 0.05) (Table 3). As shown in
TABLE 2 | PCR primers used in this study.
Gene Forward (5′ →3′) Reverse (5′ →3′)
Bax GGT TGC CCT CTT CTA CTT TGC TCT TCC AGA TGG TGA GCG AG
Bcl-2 GGA TGA CTT CTC TCG TCG CTA C TGA CAT CTC CCT GTT GAC
GCT
Shh AAG CTG GTG AAG GAC TTA CG AAA GAG CGC GCT TGG C
Gli-1 TAG ATG AAG CTC AAG GGC TG TAG CCA TTTA GGA GAC GTG G
Ptch TGG CCT CGG CTG GTA AC ATA TGA GGA GAC CCA CAA CC
β-actin CTA TTG GCA ACG AGC GGT TCC CAG CAC TGT GTT GGC ATA
GAG G
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TABLE 3 | Demographic information of SAH rats in different treatment
(total sample size: n = 120).
Group
Characteristics SAH+ SAH+ SAH+PUR Total p-Values
Vehicle PUR +Cyc number
Dead number 5 6 4 15 <0.05#
Survival number 23 72 20 115
Total 28 78 24 120
#Pearson Chi-Squared test.
FIGURE 1 | PUR attenuated SAH-induced neurological deficits and
brain edema. (A) Neurological scores were recorded at 48 h after SAH, n =
15. (B) Brain water content of cerebral cortex was measured at 48 h after
SAH, n = 6. Values represent the mean ± SD. **p < 0.01, ***p < 0.001 SAH
vs. Sham, #p < 0.05, ##p < 0.01 SAH+PUR vs. SAH, &p < 0.05
SAH+PUR+Cyc vs. SAH+PUR.
Figure 1A, the neurological deficits in SAH groups increased
significantly compared to the sham group (p < 0.001). However,
PUR treatment at 0.5, 1 and 5 mg/kg reduced neurological
deficits compared with those in the SAH+vehicle group after 48
h SAH (p < 0.05, p < 0.01, p < 0.01, respectively). Co-treatment
with Cyc, a SMO antagonist, suppressed this effect compared to
SAH+PUR.
As shown in Figure 1B, the brain water content was markedly
elevated (p < 0.01) in SAH groups in comparison with the sham
group, while after PUR administration at 0.5, 1, and 5 mg/kg, the
brain edema was dramatically attenuated (p< 0.05, p< 0.01, p<
0.01, respectively).
PUR Alleviates SAH-Induced Brain Injury
As shown in Figure 2, HE staining showed that the PFC in the
sham group has clear structural layers and neurons presented
clear borderline. While in SAH group, cells were arranged
sparsely, and the cell outline was fuzzy. Moreover, neurons were
shrunken, and obvious edema was found in the PFC which was
pale, in SAH group. Treatment with PUR in SAH reduced brain
edema and this morphological damage (Figure 2).
The TUNEL staining showed that apoptotic cells were rare
in the PFC in the sham group, while that TUNEL-positive cells
in PFC were significantly increased at 48 h after SAH insult
(p < 0.001). Administration of PUR at 0.5, 1, and 5 mg/kg
significantly decreased the TUNEL-positive neurons (p < 0.05, p
< 0.001, p< 0.001, respectively, Figure 3) in comparisonwith the
SAH+vehicle group.Moreover, Co-treatment with Cyc increased
TUNEL-positive cells compared to SAH+PUR group.
The Effect of PUR on Caspase-3 Activation
after SAH
NeuN is a neuronal-specific nuclear protein, which is expressed
in most neurons in the brain. To investigate the potential
protective mechanism of PUR, we performed active caspase-
3/NeuN staining after SAH. Figure 4 showed that numerous
active caspase-3/NeuN double positive-stained neurons were
observed in the PFC of SAH group, when compared with the
sham rats (p < 0.001). However, intervention with PUR at 0.5,
1, and 5 mg/kg significantly reduced the active caspase-3/NeuN
double positive-stained neurons in SAH group (p < 0.05, p <
0.05, p < 0.05, respectively, Figures 4A,B), compared with the
vehicle-treated SAH group.
In the SAH group, the level of cleaved caspase-3 expression
in the PFC were significantly increased (p< 0.001, Figure 4C)
when compared with the sham rats by Western blot analysis.
Co-treatment with PUR at 1 and 5 mg/kg reduced (p < 0.01,
p < 0.01, respectively) the level of cleaved caspase-3 expression
(Figure 4C), as compared with the SAH groups. And co-
treatment with Cyc reversed this effect compared to SAH+PUR.
Influence of PUR on SAH-Induced
Changes of Bcl-2 and Bax
To further confirm the anti-neuronal apoptotic effects of
PUR against SAH insult, the expressions of Bcl-2 and Bax
were examined by Western blotting and RT-PCR. As shown
in Figure 5, the expression of Bcl-2 was significantly down-
regulated, while the expression of Bax was up-regulated after
SAH insult. The ratio of Bax/Bcl-2 ratio expression was
dramatically increased both at mRNA and protein levels at 48
h after SAH insult. However, PUR treatment almost completely
reversed the decreasing of Bcl-2 and Bax expression, as well as the
altered ratio of Bax/Bcl-2. Co-treatment with Cyc suppressed this
effect compared to SAH+PUR groups.
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FIGURE 2 | PUR ameliorated SAH-induced brain injury. (A) HE staining of the brain tissues was taken at 48 h after SAH. Pathological changes represent focal
edema and neuronal cell death (marked by black arrow) in the prefrontal cortex (PFC). The high magnification shows representative normal or damaged cells, n = 4.
Scale bar = 50 µm. (B) Bar graphs showing quantification of eosinophilic cells with pyknotic nuclei detected in the PFC, n = 4. Values represent the mean ± SD. ***p
< 0.001 SAH vs. Sham, ##p < 0.01, ###p < 0.001 SAH+PUR vs. SAH, &&p < 0.01 SAH+PUR+Cyc vs. SAH+PUR.
PUR Stimulates ERK1/2 Hosphoryation
after SAH
The roles of ERK1/2 pathways upon the neuroprotective effects
of PUR were assessed using Western blot analysis. As shown
in Figure 6, SAH insult significantly decreased (p< 0.001) the
level of phosphorylation of ERK1/2. The intervention with PUR
(0.5 and 1 mg/kg) dramatically increased (p < 0.05, p < 0.05,
respectively) the level of phosphorylation of ERK1/2 in the SAH
group. And Co-treatment with Cyc inhibited the effect of PUR
on ERK1/2 activation.
Effects of the PUR on MDA Levels and
Nrf2/ HO-1 Expression after SAH
MDA can result in tissues and cells damage, thus the content
of MDA reflects the level of ROS (Wu et al., 2015). As shown
in Figure 7A, the MDA levels in SAH group were significantly
increased (p < 0.05) as compared to the sham rats. The
intervention with PUR at 0.5, 1, and 5 mg/kg significantly
decreased (p < 0.05, p < 0.001, p < 0.001, respectively) the level
of MDA in the SAH group
As is shown in Figure 7B, Western blot analysis showed
that the expressions of Nrf2 and HO-1 were increased in the
SAH group, as opposed to the sham group. Moreover, PUR
administration further increased the levels of Nrf2 and HO-1 in
the SAH group. Co-treatment with Cyc increased MDA levels
and down-regulated the expressions of Nrf2 andHO-1 compared
to SAH+PUR group.
Effects of the PUR on Shh Signaling
We next evaluated the involvement of Shh signaling molecules
in the anti-apoptotic activity of PUR by examining their
expression in the PFC at 48 h after treatment. As shown in
Figure 8, the mRNA and protein levels of Shh and Gli-1 were
markedly decreased after SAH injury, while PUR administration
significantly increased the levels of Shh and Gli-1 in the SAH
group. In addition, PUR administration reversed the SAH-
induced Ptch expression. And Co-treatment with Cyc suppressed
this effect compared to SAH+PUR.
DISCUSSION
Accumulating evidence has shown that EBI largely contributes
to poor outcomes of the patients surviving SAH (Bederson et al.,
2009), thus effective treatment of EBI may improve the clinical
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FIGURE 3 | PUR attenuates SAH-induced apoptosis. The detection of TUNEL-positive cells in PFC was taken at 48 h after SAH. Scale bar = 50 µm. Bar graphs
showing quantification of TUNEL-positive cells, n = 3. Values represent the mean ± SD. ***p < 0.001 SAH vs. Sham, #p < 0.05, ###p < 0.001 SAH+PUR vs.
SAH, &&p < 0.01 SAH+PUR+Cyc vs. SAH+PUR.
FIGURE 4 | The effect of PUR on caspase-3 activation in SAH. (A) Immunofluorescene study showed double stating of active caspase-3 (green) and NeuN (red)
of PFC at 48 h after SAH. Scale bar = 50 µm. (B) Bar graphs showing quantification of active caspase-3/NeuN-positive cells, n = 4. (C) The expression of cleaved
caspase-3 was assessed using western blot analysis. Bar graphs showing quantification of the protein levels of cleaved caspase-3 and caspase-3 were determined
by Image-Pro Plus 6.0. Results were expressed as cleaved caspase-3/caspase-3 ratio, n = 3. Values represent the mean ± SD. ***p < 0.001 SAH vs. Sham,
##p < 0.01, ###p < 0.001 SAH+L-Cys vs. SAH, &p < 0.05 SAH+PUR+Cyc vs. SAH+PUR.
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FIGURE 5 | Effects of treatment with PUR on Bax, Bcl-2 in mRNA and protein levels. (A) The relative expression levels of Bax and Bcl-2 mRNA in the PFC
were analyzed by RT-PCR. The densities of the protein bands were analyzed and normalized to β-actin, n = 3. (B) Representative western blots showing levels of Bax
and Bcl-2 in the PFC, Bar graphs showing quantification of the protein levels of Bax and Bcl-2, n = 3. Both the determination of the two signs in mRNA and protein
levels were obtained from three separate experiments. Values represent the mean ± SD. ***p < 0.001 SAH vs. Sham, ##p < 0.01, ###p < 0.001 SAH+PUR vs.
SAH, &p < 0.05, &&&p < 0.001 SAH+PUR+Cyc vs. SAH+PUR.
FIGURE 6 | The effect of PUR on the expression of ERK activation. At
48 h after SAH, entire PFC extracts were subjected to western blot analysis
using an antibody against p-ERK and ERK. Bar graphs showing quantification
of expression levels of p-ERK/ERK were determined by the Image-Pro Plus
6.0, n = 3. Values represent the mean ± SD. ***p < 0.001 SAH vs. Sham, #p
< 0.05 SAH+PUR vs. SAH, &p < 0.05 SAH+PUR+Cyc vs. SAH+PUR.
prognosis of patients surviving SAH. In the present study, PUR
treatment attenuated EBI in rats following SAH, for example,
inhibiting cell death and attenuating brain edema, as well as
improving neurological deficits and mortality. Moreover, PUR
decreased MDA levels and up-regulated NrF2 and HO-1 levels
in PFC post-SAH, associated with affecting the expression of Shh
pathway protein. The effects initiated by PUR were significantly
abrogated by Smo antagonist administration.
Many studies suggested that Shh pathway played an important
role in the development of neurodegenerative diseases and
brain injury (Dai et al., 2011; Huang et al., 2013; Chechneva
et al., 2014; Chen et al., 2015). Recently, PUR, as an agonist
of potential oncogenic Shh signaling, exhibits anti-apoptotic
effect, and promotes tissue regeneration after ischemic stroke
(Chechneva et al., 2014). In the present study, PUR significantly
attenuated brain edema, improved neurobehavioral function,
and ameliorated neuronal cell death in the PFC, suggesting PUR
plays protective effects in SAH development. With regard to
neuroprotection of PUR, there exists only limited information
on this topic which consists of data demonstrating that PUR has
anti-apoptotic, anti-inflammatory, and pro-angiogenic effects in
the ischemic cortex after ischemic insult (Chechneva et al., 2014;
Chechneva and Deng, 2015). Apoptosis is considered to be
one of the most crucial factors that can exacerbate EBI after
SAH. Moreover, damaged neurons following SAH contribute
to delayed neurological outcomes (Sabri et al., 2008). ERK
pathway controls various cell responses, such as proliferation,
differentiation, motility, survival, and metabolism (White et al.,
2000; Rauch et al., 2011). ERK phosphorylation can protect cells
from apoptosis via transcriptional regulation of anti-apoptotic
protein, such as the Bcl-2 and Mcl-1. ERK phosphorylation also
results in the phosphorylation of the pro-apoptotic Bim protein
(McCubrey et al., 2007), and then prevents Bax activation. The
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FIGURE 7 | Effects of the PUR on MDA levels and Nrf2 and HO-1 Expression after SAH. (A) At 48 h after SAH, entire PFC extracts were subjected to MDA
analysis using a commercial kit, n = 6. Values represent the mean ± SD. (B) At 48 h after SAH, entire PFC extracts were subjected to western blot analysis using an
antibody against Nrf2 and HO-1. (C,D) Bar graphs showing quantification of levels of Nrf2 and HO-1 were determined by Image-Pro Plus 6.0, n = 3. *p < 0.05, ***p <
0.001 SAH vs. Sham, #p < 0.05, ##p < 0.01, ###p < 0.001 SAH+L-Cys vs. SAH, &&p < 0.05, &&&p < 0.05 SAH+PUR+Cyc vs. SAH+PUR.
previous studies reported that the phosphorylation of ERK was
decreased in brain after SAH insult and increase of its expression
was associated with ameliorating neuronal cell death (Lin et al.,
2009; Li et al., 2016). In agreement with these studies, we found
that SAH insult decreased p-ERK level, while treatment with PUR
significantly enhanced ERK phosphorylation.
Accumulating evidence has demonstrated that oxidative stress
plays an important role in the development of EBI (Ayer
and Zhang, 2008; Duan et al., 2016). Following insults like
hypoxia-ischemic or SAH, the production of reactive oxygen
species (ROS) exceeds the ability of the endogenous anti-oxidant
system, leading to oxidative stress and cell death (Wu et al.,
2014; Zhang et al., 2016). Excessive production of ROS results
in protein breakdown, lipid peroxidation, and DNA damage,
leading to neuronal damage, BBB disruption, cellular apoptosis,
and endothelial injury (Ayer and Zhang, 2008). Given the
pathogenic impact of oxidative stress, therapeutic strategies
aimed to blunt the processes are considered as an effective way
to confer neuroprotection in SAH. A recent study demonstrated
that PUR protected hippocampal neurons against injury through
inhibition of oxidative stress (Peterson and Turnbull, 2012).
In the present study, we found that the SAH insult increased
MDA levels accompanied with decreased Shh, Gli-1 expression,
and up-regulated Ptch expression, while PUR administration
reversed MDA levels and Shh signaling molecules. Moreover, the
neuroprotection of PUR on SAH was blocked by Smo antagonist
Cyc. These results indicate that oxidative stress may be involved
in an impaired Shh pathway following SAH, leading to neuronal
damage and neurological deficits. Anti-oxidative strategies aimed
at restoring the endogenous Shh pathway may offer an effective
way to promote neurological function.
Nrf2 has been shown to be an important antioxidant
protection in various CNS diseases, including SAH (Chen et al.,
2011; Wu et al., 2014), traumatic brain injury (Jin et al., 2008),
and neurodegenerative disorders (van Muiswinkel and Kuiperij,
2005). Under the pathological conditions, such as ROS, Nrf2
rapidly translocates from the cytoplasm to the nucleus. In the
nucleus, Nrf2 binds to antioxidant-response element (ARE)
and then activates ARE-dependent gene expression, such as
heme oxygenase-1 (HO-1), NAD(P)H:quinone oxidoreductase
1, glutamate-cysteine ligase, glutathione peroxidase (Magesh
et al., 2012). In the CNS, HO-1 was reported to be active in
protecting cells exposed to oxidizing agents by catalyzing the
oxidation of heme to biologically active products, including
carbon monoxide, biliverdin, and ferrous iron (Syapin, 2008).
Therefore, pharmacological activation of Nrf2/HO-1 system is
critical for the protection of cells exposed to oxidative stress
insults related to SAH (Chen et al., 2011). In the present study,
we found that SAH induced a significant increase in Nrf2 protein
levels in the PFC. The levels of Nrf2-regulated gene products,
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FIGURE 8 | Effects of PUR on Shh pathway. The quantification of Shh, Gli-1, and Ptch was measured by RT-PCR (A) and western blot (B) 48 h post-SAH. Each
value was normalized to β-actin. Bar graphs showing quantification of mRNA and protein levels of Shh, Gli-1, and Ptch were determined by Image-Pro Plus 6.0, n =
3. Values represent the mean ± SD. **p < 0.01, ***p < 0.001 SAH vs. Sham, #p < 0.05, ##p < 0.05, ###p < 0.001 SAH+PUR vs. SAH, &p < 0.05, &&p <
0.01 SAH+PUR+Cyc vs. SAH+PUR.
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FIGURE 9 | A potential process illustrates the effects of PUR on early
brain injury following SAH and the underlying mechanisms. Briefly,
treatment with PUR activated Ptch and caused Smo release. Then Gli-1
translocated to the nucleus, further up-regulated Bcl-2 expression and
down-regulated Bax expression.
HO-1 was also up-regulated at 48 h after SAH, reinforcing
previous report (Chen et al., 2011). Importantly, administration
of PUR attenuated MDA levels and reduced the EBI in SAH rats,
associated with an increase in the Nrf2 and HO-1 expression.
However, the specific mechanism of activation of the Nrf2/HO-1
system by PUR has not been completely unknown, which needs
to be investigated in further studies.
It should be noted that as recently researches indicated in
the experimental SAH model, the Shh pathway (Shh, Gli-1,
and Ptch) was up-regulated after 24 and 48 h injury, and Cyc
administration at 10 mg/ml aggravated brain injury in SAH (Li
et al., 2013). However, Zuo et al. showed that the protein of
Shh was decreased at 24 h post-SAH (Zuo et al., 2015). In the
study, we also found that at 48 h after SAH insult, Shh and
Gli-1 expression were down-regulated. Notably, the expression
of Ptch was up-regulated at 48 h post-SAH. Administration of
Cyc alone at 1 mg/ml did not affect brain injury in SAH, while
co-treatment with Cyc blocked the neuroprotective effects of
PUR on SAH (Figure 9). There are a number of reasons for the
inconsistencies in Shh pathway change after SAH insult. The
different stimulating condition used in these studies maybe the
main reason for these discrepancies, such as SAHmodel, the dose
of Cyc administration.
However, our study has several limitations. Firstly, the cellular
location of Shh, Gli-1, and Ptch, and the underlying mechanism
of these proteins in SAH were not investigated. In addition,
PUR may have other protective effects against EBI that were
not evaluated in this study, such as anti-inflammatory and
immunomodulatory properties. Lastly, only the tissue in PFC
was analyzed, however, other brain regions, for example the
hippocampus have increased neuronal apoptosis following SAH
insult. Thus, the neuroprotective properties of PUR in SAH may
also occur in other brain regions. Therefore, further studies are
necessary.
In conclusion, we demonstrated that the Shh signaling agonist
PUR plays a neuroprotective property during EBI after SAH
insult and suggested PUR as a potential candidate in SAH
therapy. The action of PUR was mediated in part by its anti-
apoptotic and anti-oxidant mechanism, up-regulating phospho-
ERK levels, mediating Shh signaling molecules in the PFC.
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